» Articles » PMID: 36001423

Differential Expression of MiR-1249-3p and MiR-34b-5p Between Vulnerable and Resilient Phenotypes of Cocaine Addiction

Overview
Journal Addict Biol
Specialty Psychiatry
Date 2022 Aug 24
PMID 36001423
Authors
Affiliations
Soon will be listed here.
Abstract

Cocaine addiction is a complex brain disorder involving long-term alterations that lead to loss of control over drug seeking. The transition from recreational use to pathological consumption is different in each individual, depending on the interaction between environmental and genetic factors. Epigenetic mechanisms are ideal candidates to study psychiatric disorders triggered by these interactions, maintaining persistent malfunctions in specific brain regions. Here we aim to study brain-region-specific epigenetic signatures following exposure to cocaine in a mouse model of addiction to this drug. Extreme subpopulations of vulnerable and resilient phenotypes were selected to identify miRNA signatures for differential vulnerability to cocaine addiction. We used an operant model of intravenous cocaine self-administration to evaluate addictive-like behaviour in rodents based on the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition criteria to diagnose substance use disorders. After cocaine self-administration, we performed miRNA profiling to compare two extreme subpopulations of mice classified as resilient and vulnerable to cocaine addiction. We found that mmu-miR-34b-5p was downregulated in the nucleus accumbens of vulnerable mice with high motivation for cocaine. On the other hand, mmu-miR-1249-3p was downregulated on vulnerable mice with high levels of motor disinhibition. The elucidation of the epigenetic profile related to vulnerability to cocaine addiction is expected to help find novel biomarkers that could facilitate the interventions to battle this devastating disorder.

Citing Articles

Substance-Induced Psychiatric Disorders, Epigenetic and Microbiome Alterations, and Potential for Therapeutic Interventions.

Nohesara S, Mostafavi Abdolmaleky H, Thiagalingam S Brain Sci. 2024; 14(8).

PMID: 39199463 PMC: 11352452. DOI: 10.3390/brainsci14080769.


Hsa-microRNA-1249-3p/Homeobox A13 axis modulates the expression of β-catenin gene in human epithelial cells.

Mazziotta C, Iaquinta M, Tramarin M, Badiale G, Cervellera C, Tonnini G Sci Rep. 2023; 13(1):22872.

PMID: 38129477 PMC: 10739948. DOI: 10.1038/s41598-023-49837-0.


miRNAs and Substances Abuse: Clinical and Forensic Pathological Implications: A Systematic Review.

Occhipinti C, La Russa R, Iacoponi N, Lazzari J, Costantino A, Di Fazio N Int J Mol Sci. 2023; 24(23).

PMID: 38069445 PMC: 10707252. DOI: 10.3390/ijms242317122.


Functional genomic mechanisms of opioid action and opioid use disorder: a systematic review of animal models and human studies.

Falconnier C, Caparros-Roissard A, Decraene C, Lutz P Mol Psychiatry. 2023; 28(11):4568-4584.

PMID: 37723284 PMC: 10914629. DOI: 10.1038/s41380-023-02238-1.


THC exposure during adolescence increases impulsivity-like behavior in adulthood in a WIN 55,212-2 self-administration mouse model.

Cajiao-Manrique M, Casado-Anguera V, Garcia-Blanco A, Maldonado R, Martin-Garcia E Front Psychiatry. 2023; 14:1148993.

PMID: 37304451 PMC: 10248087. DOI: 10.3389/fpsyt.2023.1148993.


References
1.
Evangelou E, Gao H, Chu C, Ntritsos G, Blakeley P, Butts A . New alcohol-related genes suggest shared genetic mechanisms with neuropsychiatric disorders. Nat Hum Behav. 2019; 3(9):950-961. PMC: 7711277. DOI: 10.1038/s41562-019-0653-z. View

2.
Maldonado R, Calve P, Garcia-Blanco A, Domingo-Rodriguez L, Senabre E, Martin-Garcia E . Vulnerability to addiction. Neuropharmacology. 2021; 186:108466. DOI: 10.1016/j.neuropharm.2021.108466. View

3.
Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

4.
Jonkman S, Kenny P . Molecular, cellular, and structural mechanisms of cocaine addiction: a key role for microRNAs. Neuropsychopharmacology. 2012; 38(1):198-211. PMC: 3521966. DOI: 10.1038/npp.2012.120. View

5.
Chou C, Shrestha S, Yang C, Chang N, Lin Y, Liao K . miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic Acids Res. 2017; 46(D1):D296-D302. PMC: 5753222. DOI: 10.1093/nar/gkx1067. View